Azacitidin Zentiva 25 mg/ml Pulver zur Herstellung einer Injektionssuspension, Azacitidine 25 mg/mL powder for suspension for injection, SY-1425, Placebo for Tamibarotene (SY-1425), AZACITIDINE
SY-1425-301
Phase 3 small_molecule active
Quick answer
Azacitidin Zentiva 25 mg/ml Pulver zur Herstellung einer Injektionssuspension, Azacitidine 25 mg/mL powder for suspension for injection, SY-1425, Placebo for Tamibarotene (SY-1425), AZACITIDINE for Newly Diagnosed RARA-positive Adult Patients with Higher-risk Myelodysplastic Syndrome is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Newly Diagnosed RARA-positive Adult Patients with Higher-risk Myelodysplastic Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active